Skip to main content

Table 2 Outcomes in different types ARDS patients

From: Comparison of community-acquired, hospital-acquired, and intensive care unit-acquired acute respiratory distress syndrome: a prospective observational cohort study

Outcomes

Community-acquired ARDS

Hospital-acquired ARDS

ICU-acquired ARDS

p

 

(n = 70)

(n = 83)

(n = 143)

 

Mortality –no.(% [95 % CI])

 In ICU

26 (37*[26–49])

51 (61[51–72])

75 (52[44–61])

0.001

 At 28-day

31 (44*[33–56])

56 (68[57–78])

89 (62[54–70])

0.012

 At 60-day

33 (47*[35–59])

58 (70[60–80])

92 (64[56–72])

0.001

 At 90-day

33 (47*[35–59])

59 (71[61–81])

97 (68[60–76])

0.001

 In hospital

34 (49*[37–60])

61 (74[64–83])

97 (68[60–76])

0.001

No. of ventilator-free days, days 1 to 28

16 ± 9

14 ± 10

11 ± 9†

0.001

No. of ICU-free days, Days 1 to 28

8 ± 10*

4 ± 8

3 ± 6

0.001

  1. Abbreviations: ARDS acute respiratory distress syndrome, MV mechanical ventilation, LOS length of stay, ICU intensive care unit
  2. All values are expressed as No of patients (% [95 % CI]) or mean ± SD
  3. * p < 0.05: Community-acquired ARDS vs. hospital-acquired ARDS and vs ICU-acquired ARDS
  4. † p < 0.05: ICU-acquired ARDS vs. Community-acquired ARDS and vs Hospital-acquired ARDS